Search Within

Alexander Edward Drilon

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (101)
  2. Journal Article (93)
  3. Review (7)
  4. Research Letter (2)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (205)
  2. Department of Pathology and Laboratory Medicine (205)
  3. Solid Tumor Oncology Division (205)
  4. Thoracic Oncology (205)
  5. GSK Faculty (167)
  6. Human Oncology and Pathogenesis Program (150)

More Groups

People
  1. Marc Ladanyi (121)
  2. Maria Arcila (82)
  3. Mark Kris (73)
  4. Charles Rudin (53)
  5. Gregory Riely (52)
  6. Michael Berger (51)

More People

Years
  1. 2025 (4)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (20)
  5. 2021 (20)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (49)
  2. Journal of Thoracic Oncology (24)
  3. Clinical Cancer Research (17)
  4. JCO Precision Oncology (14)
  5. Cancer Research (12)
  6. Cancer Discovery (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (64)
  2. American Association for Cancer Research (42)
  3. Elsevier Inc. (30)
  4. Nature Publishing Group (19)
  5. Oxford University Press (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (205)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of solid tumors with BRAF fusions
    Meeting Abstract

    Chen, M. F.; Yang, S. R.; Tao, J.; Desilets, A.; Rosen, E.; Gong, Y.; Mullaney, K. A.; Kris, M. G.; Arcila, M. E.; Donoghue, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort
    Meeting Abstract

    Repetto, M.; Richards, A. L.; Chen, M. F.; Zhu, Y.; Selenica, P.; Gazzo, A.; Lee, P.; Price, A.; Yang, S. R.; Marra, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ctDNA analysis of NTRK fusion and mechanisms of acquired resistance to TRK inhibitors
    Meeting Abstract

    Sivaprakasam, K.; Harada, G.; Choudhury, N. J.; Savin, C.; Shah, R. H.; Berger, M. F.; Drilon, A. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Quantifying the growth of clinical actionability in precision oncology using OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • RET-altered cancers—A tumor-agnostic review of biology, diagnosis and targeted therapy activity
    Review

    Desilets, A.; Repetto, M.; Yang, S. R.; Sherman, E. J.; Drilon, A.
    Cancers (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Rare molecular subtypes of lung cancer
    Review

    Harada, G.; Yang, S. R.; Cocco, E.; Drilon, A.
    Nature Reviews Clinical Oncology (2023)

    Fulltext@MSK | Save